Indole: The molecule of diverse biological activities

Asian Journal of Pharmaceutical and Clinical Research

Volumn 5, Issue 1, 2012, Pages 1-6

  Biswal, S ^a   Sahoo, U ^a   Sethy, S ^a   Kumar, H K S ^a   Banerjee, M ^a  

^a INSTITUTE OF PHARMACY AND TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMEDALIN; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; APAZIQUONE; ARBIDOL; BINEDALINE; CEDIRANIB; DELAVIRDINE; DOLASETRON MESILATE; INDALPINE; INDOLE DERIVATIVE; MITRAPHYLLINE; NAVELBINE; OXYPERTINE; PANOBINOSTAT; PERINDOPRIL; PINDOLOL; PRAVADOLINE; RESERPINE; ROXINDOLE; SIRAMESINE; TRANDOLAPRIL; TROPISETRON; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; VINCAMINE; VINCRISTINE; VINDESINE; YOHIMBINE; ZAFIRLUKAST;

BIOLOGICAL ACTIVITY; DRUG EFFECT; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG STRUCTURE; HUMAN; REVIEW; SEXUAL DYSFUNCTION;

EID: 84857022775     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Delgado JN and Remers WA. Wilson and Giswold's. Textbook of Organic Chemistry Medicinal and Pharmaceutical Chemistry. 10th ed. Philadelphia: Lippincott Raven; 1998.
2. The Science and Practice of Pharmacy. 19th ed. Pennsylvania: MACK Publishing Company; 1995. p. 425.
3. Jake Hooker and Walt Bogdanich, Tainted Drugs Tied to Maker of Abortion Pill, New York Times, January 31, 2008.
4. Jordan MA, Leslie W, Microtubules as a target for anticancer drugs, Nat Rev Cancer, Apr 4, 2004 [1].
5. Jordan MA, Leslie W, Microtubules as a target for anticancer drugs, Nat Rev Cancer, Apr 4, 2004.
6. García Giménez D, García Prado E, Sáenz Rodríguez T, Fernández Arche A, De la Puerta R. "Cytotoxic effect of the pentacyclic oxindole alkaloid mitraphylline isolated from Uncaria tomentosa bark on human Ewing's sarcoma and breast cancer cell lines". Planta Med 76 (2): 133-136. (2010).
7. Puri, R. et al. Phase I/II Pilot Study of Intravesical Apaziquone (EOquin) for Superficial Bladder Cancer. The Journal of Urology, Volume 176, Issue 4, Pages 1344-1348.
8. Wedge SR, Kendrew J, Hennequin LF, et al. AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer. Cancer Res. 65 (10): 4389-400. (May 2005).
9. Prince, HM; M Bishton Panobinostat (LBH589): a novel pan-deacetylase inhibitor with activity in T cell lymphoma. Hematology Meeting Reports (Parkville, Australia: Peter MacCallum Cancer Centre and University of Melbourne) 3 (1): 33-38. (2009).
10. Cook, P; James, I Cerebral vasodilators. N Engl J Med. 305 (26): 1560-1564. (Dec. 24, 1981).
11. Chobanian AV, Bakris GL, Black HR, et al. (2003). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (19): 2560-72.
12. Bounhoure JP, Bottineau G, Lechat P, et al. Value of perindopril in the treatment of chronic congestive heart failure: multicentre double-blind placebo-controlled study. Clin Exp Hypertens.;A11(suppl 2):575-586, 1989.
13. A controlled double-blind study comparing binedaline and imipramine in the treatment of endogenous depression. Neuropsychobiology 12 (1): 34-38, (1984).
14. Tan, X; He, W; Liu, Y,Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy. Kidney international 76 (12): 1248-57.
15. Canas-Rodriquez A, Leeming PR (1972). N-Phenyl-2-indolinones and N-phenylindolines - New class of antidepressant agents. Journal of Medicinal Chemistry 15 (7): 762-770., (2009).
16. Isaac MT Review: combining pindolol with an SSRI improves early outcomes in people with depression. Evid Based Ment Health 7 (4): 107. (November 2004).
17. Romero AG, Leiby JA, McCall RB, Piercey MF, Smith MW, Han F.,Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants. J Med Chem. 36 (15): 2066-2074. (1993).
18. Hall, Chapman and Rhodes, P. H (1996). Dictionary of organic compounds. London: Chapman & Hall.
19. Gründer G, Wetzel H, Hammes E, Benkert O,Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression. Psychopharmacology 111 (1): 123-6. (1993).
20. Shopsin, B; Friedman, E; Gershon, S,Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients. Archives of general psychiatry 33 (7): 811-9. (1976).
21. DHHS panel. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (May 4, 2006).
22. Ostojic SM,Yohimbine: the effects on body composition and exercise performance in soccer players. Research in Sports Medicine 14 (4): 289-99. (2006).
23. Katzung, Bertram G. Basic and Clinical Pharmacology, 9th ed. ISBN 0-07-141092-9, (2004).
24. Macor JE, Gurley D, Lanthorn T, Loch J, Mack RA, Mullen G, Tran O, Wright N, Gordon JC The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist. Bioorganic & Medicinal Chemistry Letters 11 (3): 319. (February 2001).
25. Bell MR, D'Ambra TE, Kumar V, et al. Antinociceptive (aminoalkyl)indoles. J. Med. Chem. 34 (3): 1099-110., (1991).
26. Fischer JD, Song MH, Suttle AB, Heizer WD, Burns CB, Vargo DL, Brouwer KL. Comparison of zafirlukast (Accolate) absorption after oral and colonic administration in humans. Pharmaceut. Res. 17: 154-159, 2000.
27. Leneva IA, Russell RJ, Boriskin YS, Hay AJ (February 2009). Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol. Antiviral Res. 81 (2): 132-40.
28. Morse GD, Reichman RC, Fischl MA, et al. (January 2000). Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams. Antiviral Res. 45 (1): 47-58.
29. Cochet-Meilhac M, Chambon P Animal DNA-dependent RNA polymerases. 11. Mechanism of the inhibition of RNA polymerases B by amatoxins. Biochim. Biophys. Acta 353 (2): 160-84., (June 1974).
30. Willette RN, Mitchell MP, Ohlstein EH, Lukas MA, Ruffolo RR,Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart. Pharmacology 56 (1): 30-6. (January 1998).
31. Wieland, Heinrich; Konz, Wilhelm; Mittasch, Heinz,Toad poisons. VII. Constitution of bufotenin and bufotenidine. Justus Liebigs Annalen der Chemie 513: 1-25. (1934).
32. Morse GD, Reichman RC, Fischl MA, et al. Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams. Antiviral Res. 45 (1): 47-58., (January 2000).
33. Takayama H, Ishikawa H, Kurihara M, Kitajima M, Aimi N, Ponglux D, Koyama F, Matsumoto K, Moriyama T, Yamamoto LT, Watanabe K, Murayama T, Horie S,Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands. J. Med. Chem. 45 (9): 1949-56. (April 2002).
34. Margaret F. Roberts, Michael Wink. Alkaloids: Biochemistry, Ecology, and Medicinal Applications. Pp68-69.
35. Rosengren, A. H.; Jokubka, R.; Tojjar, D.; Granhall, C.; Hansson, O.; Li, D.-Q.; Nagaraj, V.; Reinbothe, T. M. et al.,Overexpression of Alpha2A-Adrenergic Receptors Contributes to Type 2 Diabetes. Science 327 (5962): 217-20. (2009).